Among the subjects with T1D, 18% of subjects were triple antibody-positive, 36% were double antibody-positive subjects (20% were anti-GAD65 and IA-2 positive, 11% were anti-GAD65, and insulin-positive and 5% were IA-2 and insulin-positive). This evidence concerns the gene INS and type 1 diabetes mellitus.